Investigator Site #122 — Louisville, Kentucky

Investigator Site #122 is a clinical research site located in Louisville, Kentucky, United States 40202.

Crixeo Health Trust Score: 44/100 (POOR). This profile has not yet been claimed by the site owner.

Investigator Site #122 has participated in 1 clinical trials.

Therapeutic areas: Exocrine Pancreatic Insufficiency, Cystic Fibrosis.

Sponsors: Anthera Pharmaceuticals.

Sponsor Feasibility Report

Trust Score: 44/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Investigator Site #122?

Investigator Site #122 has a Crixeo Trust Score of 44/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Investigator Site #122 conducted?

Investigator Site #122 has 1 clinical trials on record. Their work covers Exocrine Pancreatic Insufficiency, Cystic Fibrosis.

Is Investigator Site #122 accredited by Crixeo Health?

Investigator Site #122 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Investigator Site #122?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.